Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

15.28 -0.56 (-3.54%)
Streaming Delayed Price Updated: 2:20 PM EST, Mar 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 130,560
Open 15.84
Bid (Size) 15.28 (100)
Ask (Size) 15.63 (300)
Prev. Close 15.84
Today's Range 14.55 - 16.45
52wk Range 3.095 - 22.86
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
From Prenetics Global Limited
Via GlobeNewswire

Performance

YTD
-3.2%
-3.2%
1 Month
-21.3%
-21.3%
3 Month
+3.5%
+3.5%
6 Month
+87.5%
+87.5%
1 Year
+208.7%
+208.7%

More News

Read More
Prenetics Global Ltd. (NASDAQ:PRE) Reports Q4 Revenue Beat and Narrower Loss on IM8 Strength ↗
Via Chartmill
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Earnings Scheduled For November 10, 2025 ↗
Via Benzinga
News headline image
Prenetics Global's Earnings: A Preview ↗
Via Benzinga
News headline image
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Update to Capital Allocation Strategy; Ceases Bitcoin Purchases to Focus on IM8
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Upcoming Conference Participation
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Cantor Fitzgerald Reiterates Overweight Rating on Prenetics with Price Target of $31 Following Strong IM8 Growth
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Bitcoin Whales Unleash Torrent of Sales, Sending Market into “Extreme Fear” as Price Dips Below $100,000
Via BreakingCrypto
Topics ETFs Economy
News headline image
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Achieves Record $9 Million in Revenue for October, Surpasses $108 Million in Annualized Recurring Revenue 11 Months After Launch
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Bolsters Bitcoin Treasury with Strategic Acquisition of 100 Bitcoin, IM8 Reaches $100M ARR
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Bitcoin's 'Uptober' Streak Ends: First Monthly Loss Since 2018 Signals Shifting Market Dynamics
Via MarketMinute
Topics Derivatives ETFs Economy
News headline image
Prenetics CEO Danny Yeung Publishes "The Dual-Engine Revolution" Manifesto: A Blueprint for the Future of Health + Wealth
From Prenetics Global Limited
Via GlobeNewswire

Frequently Asked Questions

Is Prenetics Global Limited - Class A Ordinary Share publicly traded?
Yes, Prenetics Global Limited - Class A Ordinary Share is publicly traded.
What exchange does Prenetics Global Limited - Class A Ordinary Share trade on?
Prenetics Global Limited - Class A Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Prenetics Global Limited - Class A Ordinary Share?
The ticker symbol for Prenetics Global Limited - Class A Ordinary Share is PRE on the Nasdaq Stock Market
What is the current price of Prenetics Global Limited - Class A Ordinary Share?
The current price of Prenetics Global Limited - Class A Ordinary Share is 15.28
When was Prenetics Global Limited - Class A Ordinary Share last traded?
The last trade of Prenetics Global Limited - Class A Ordinary Share was at 03/03/26 02:20 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.